Scientific Industries, Inc. engages in the designing, manufacturing, and marketing of benchtop laboratory equipment. The company is headquartered in Bohemia, New York and currently employs 55 full-time employees. The firm manufactures laboratory equipment, pill counters, and bioprocessing systems under the product name DOTS. Its products are generally used for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. The Company’s Torbal division line of products includes pharmacy, laboratory, industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gauges and test stands. The Company’s second core platform, Scientific Bioprocessing, is a digitization of analog bioproduction with its real-time DOTS platform. By converting complex biological signals into machine-readable data, the platform lays the foundation for predictive, automated, and scalable biomanufacturing.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for SCND. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: SCND is a Sell candidate.
SCND stock price ended at $0.6 on 木曜日, after rising 30.43%
On the latest trading day Jul 30, 2026, the stock price of SCND rose by 30.43%, climbing from $0.54 to $0.60. During the session, the stock saw a volatility of 11.11%, with prices oscillating between a daily low of $0.54 and a high of $0.60. Notably, trading volume dropped by 7.2K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 9.4K shares were traded, equating to a market value of approximately $7.1M.